Published in J Gen Virol on December 01, 1983
Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway. Mol Cell Biol (1989) 3.49
Regulation of cell proliferation and differentiation by interferons. Biochem J (1985) 1.75
Injection of mice with antibody to mouse interferon alpha/beta decreases the level of 2'-5' oligoadenylate synthetase in peritoneal macrophages. J Virol (1985) 1.06
Priming affects the activity of a specific region of the promoter of the human beta interferon gene. Mol Cell Biol (1990) 0.91
Interferon modulation of c-myc expression in cloned Daudi cells: relationship to the phenotype of interferon resistance. Mol Cell Biol (1986) 0.90
Signals and transduction mechanisms for activation of plant defenses against microbial attack. Cell (1989) 9.42
A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem (1997) 6.52
Induction of tumor necrosis factor alpha expression in human T lymphocytes following ionizing gamma irradiation. J Interferon Cytokine Res (1996) 4.88
The CIC library: a large insert YAC library for genome mapping in Arabidopsis thaliana. Plant J (1995) 3.79
A 37 kDa 2-5A binding protein as a potential biochemical marker for chronic fatigue syndrome. Am J Med (2000) 3.54
Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection. J Exp Med (1976) 3.28
Interferon, double-stranded RNA, and protein phosphorylation. Proc Natl Acad Sci U S A (1976) 3.24
A method for the large scale production of potent interferon preparations. Proc Soc Exp Biol Med (1974) 3.01
Specific antiviral activity of a poly(L-lysine)-conjugated oligodeoxyribonucleotide sequence complementary to vesicular stomatitis virus N protein mRNA initiation site. Proc Natl Acad Sci U S A (1987) 3.00
Sequence of the chloroplast DNA region of Chlamydomonas reinhardii containing the gene of the large subunit of ribulose bisphosphate carboxylase and parts of its flanking genes. J Mol Biol (1982) 2.90
Sequence of the chloroplast 16S rRNA gene and its surrounding regions of Chlamydomonas reinhardii. Nucleic Acids Res (1982) 2.86
Developmental and environmental regulation of a phenylalanine ammonia-lyase-beta-glucuronidase gene fusion in transgenic tobacco plants. Proc Natl Acad Sci U S A (1989) 2.62
Increased rate of degradation of c-myc mRNA in interferon-treated Daudi cells. Proc Natl Acad Sci U S A (1985) 2.35
Activation of latent Epstein-Barr virus by antibody to human IgM. Nature (1978) 2.33
Intracellular distribution of microinjected antisense oligonucleotides. Proc Natl Acad Sci U S A (1991) 2.22
Differential regulation of phenylalanine ammonia-lyase genes during plant development and by environmental cues. J Biol Chem (1989) 2.17
Role of the polyadenylate segment in the translation of globin messenger RNA in Xenopus oocytes. Proc Natl Acad Sci U S A (1974) 2.05
Antitumor effects of interferon. Biochim Biophys Acta (1978) 2.04
Correlation between the antiviral effect of interferon treatment and the inhibition of in vitro mRNA translation in noninfected L cells. J Virol (1973) 2.00
Structural and transcription analysis of two homologous genes for the P700 chlorophyll a-apoproteins in Chlamydomonas reinhardii: evidence for in vivo trans-splicing. EMBO J (1987) 1.84
Purification of mouse interferon by sequential affinity chromatography on poly(U)--and antibody--agarose columns. Nature (1978) 1.81
Interferon-alpha-dependent activation of Tyk2 requires phosphorylation of positive regulatory tyrosines by another kinase. J Biol Chem (1996) 1.78
Raising antibodies to human leukocyte interferon. Acta Pathol Microbiol Scand B (1975) 1.76
Interferon, double-stranded RNA and mRNA degradation. Nature (1976) 1.70
Affinity chromatography of human leukocyte and diploid cell interferons on sepharose-bound antibodies. J Immunol (1975) 1.67
TAT peptide internalization: seeking the mechanism of entry. Curr Protein Pept Sci (2003) 1.66
Lethality of interferon preparations for newborn mice. Nature (1975) 1.65
Molecular cloning of a new interferon-induced factor that represses human immunodeficiency virus type 1 long terminal repeat expression. J Biol Chem (1995) 1.64
Transcriptional and post-transcriptional regulation of c-myc expression during the differentiation of murine erythroleukemia Friend cells. Nucleic Acids Res (1986) 1.62
Human leukocyte interferon: production, purification, stability, and animal experiments. In Vitro Monogr (1974) 1.62
Mutant U5A cells are complemented by an interferon-alpha beta receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster. EMBO J (1995) 1.61
Delivery of antisense oligonucleotides by poly(L-lysine) conjugation and liposome encapsulation. Anticancer Drug Des (1993) 1.61
Cloning and characterization of a RNAse L inhibitor. A new component of the interferon-regulated 2-5A pathway. J Biol Chem (1995) 1.60
Discrimination between messenger ribonucleic acids by a mammalian translation initiation factor. Proc Natl Acad Sci U S A (1973) 1.57
Structure and transcription of the spinach chloroplast rDNA leader region. Nucleic Acids Res (1982) 1.56
Characterization of the messenger ribonucleoprotein released from reticulocyte polyribosomes by EDTA treatment. Eur J Biochem (1971) 1.56
alpha-DNA. VI: Comparative study of alpha- and beta-anomeric oligodeoxyribonucleotides in hybridization to mRNA and in cell free translation inhibition. Nucleic Acids Res (1987) 1.53
Cell-penetrating-peptide-based delivery of oligonucleotides: an overview. Biochem Soc Trans (2007) 1.49
Production of human lymphoblastoid interferon. J Clin Microbiol (1975) 1.49
Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1. Cell Death Differ (2000) 1.49
Inhibition by anti-interferon serum of lymphocytic choriomeningitis virus disease in suckling mice. Proc Natl Acad Sci U S A (1977) 1.49
Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis. Mult Scler (2008) 1.42
Distinct domains of the protein tyrosine kinase tyk2 required for binding of interferon-alpha/beta and for signal transduction. J Biol Chem (1995) 1.41
Alpha and beta interferons and their receptor and their friends and relations. J Interferon Cytokine Res (1995) 1.41
Identification of the cell multiplication inhibitory factors in interferon preparations as interferons. Nature (1976) 1.41
Interferon receptors. Interferon (1983) 1.39
Molecular cloning of a new interferon-induced PML nuclear body-associated protein. J Biol Chem (1997) 1.37
Increased endonuclease activity in an extract from mouse Ehrlich ascites tumor cells which had been treated with a partially purified interferon preparation: dependence of double-stranded RNA;. Biochem Biophys Res Commun (1976) 1.37
Interferon messenger RNA is produced constitutively in the organs of normal individuals. Proc Natl Acad Sci U S A (1987) 1.36
Sequence requirements for premature transcription arrest within the first intron of the mouse c-fos gene. Mol Cell Biol (1991) 1.36
Release of messenger RNA from rabbit reticulocyte polyribosomes at low concentration of divalent cations. Biochim Biophys Acta (1967) 1.35
Identifying intercellular signaling genes expressed in malignant plasma cells by using complementary DNA arrays. Blood (2001) 1.34
Characterization of a chloroplast mutation in the psaA2 gene of Chlamydomonas reinhardtii. Curr Genet (1987) 1.30
No evidence for a carbohydrate moiety affecting the clearance of circulating human leukocyte interferon in rabbits. Acta Pathol Microbiol Scand B Microbiol Immunol (1974) 1.29
Electrophoretically pure mouse interferon exerts multiple biologic effects. Proc Natl Acad Sci U S A (1979) 1.28
Behavior of a cloned murine interferon alpha/beta receptor expressed in homospecific or heterospecific background. Proc Natl Acad Sci U S A (1992) 1.28
Comparative evaluation of seven oligonucleotide analogues as potential antisense agents. J Med Chem (1993) 1.27
Identification of an ancestral resistance gene cluster involved in the coevolution process between Phaseolus vulgaris and its fungal pathogen Colletotrichum lindemuthianum. Mol Plant Microbe Interact (1999) 1.27
Binding of 125I-labelled human alpha interferon to human lymphoid cells. Int J Cancer (1981) 1.25
Gene expression in scrapie. Cloning of a new scrapie-responsive gene and the identification of increased levels of seven other mRNA transcripts. J Biol Chem (1998) 1.23
Injection of mice with antibody to interferon enhances the growth of transplantable murine tumors. J Exp Med (1983) 1.22
First DNA sequence of a chloroplast mutation: a missense alteration in the ribulosebisphosphate carboxylase large subunit gene. Plasmid (1983) 1.22
Biological activity of oligonucleotide-poly(L-lysine) conjugates: mechanism of cell uptake. Bioconjug Chem (1991) 1.22
Mechanisms of interferon action: biochemical and genetic approaches. Interferon (1982) 1.22
The relationship between the interferon alpha response and viral burden in primary SIV infection. AIDS Res Hum Retroviruses (1996) 1.21
Domains of interaction between alpha interferon and its receptor components. J Mol Biol (1994) 1.21
Phenylalanine ammonia-lyase gene organization and structure. Plant Mol Biol (1989) 1.21
Shared receptor components but distinct complexes for alpha and beta interferons. J Mol Biol (1998) 1.20
Efficacy of exogenous interferon treatment initiated after onset of multiplication of vesicular stomatitis virus in the brains of mice. J Gen Virol (1975) 1.19
clk1, a serine/threonine protein kinase-encoding gene, is involved in pathogenicity of Colletotrichum lindemuthianum on common bean. Mol Plant Microbe Interact (1998) 1.18
Cell-penetrating peptide-morpholino conjugates alter pre-mRNA splicing of DMD (Duchenne muscular dystrophy) and inhibit murine coronavirus replication in vivo. Biochem Soc Trans (2007) 1.17
Silencer region of a chalcone synthase promoter contains multiple binding sites for a factor, SBF-1, closely related to GT-1. Plant Mol Biol (1991) 1.16
A20/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells. Oncogene (2007) 1.15
Interferon, double-stranded RNA and RNA degradation. Characteristics of an endonuclease activity. Eur J Biochem (1977) 1.14
Biological activities and receptor binding of two human recombinant interferons and their hybrids. J Gen Virol (1986) 1.14
Antiviral activity of conjugates between poly(L-lysine) and synthetic oligodeoxyribonucleotides. Gene (1988) 1.14
Human leukocyte interferon: a role for disulphide bonds. J Gen Virol (1974) 1.13
Single-stranded RNA viruses inactivate the transcriptional activity of p53 but induce NOXA-dependent apoptosis via post-translational modifications of IRF-1, IRF-3 and CREB. Oncogene (2006) 1.13
Blocks in elongation and initiation of protein synthesis induced by interferon treatment in mouse L cells. Eur J Biochem (1975) 1.13
Interferon treatment of Ehrlich ascites tumor cells: effects on exogenous mRNA translation and tRNA inactivation in the cell extract. J Virol (1975) 1.11
Improved biological activity of antisense oligonucleotides conjugated to a fusogenic peptide. Nucleic Acids Res (1994) 1.10
The 2-5A/RNase L/RNase L inhibitor (RLI) [correction of (RNI)] pathway regulates mitochondrial mRNAs stability in interferon alpha-treated H9 cells. J Biol Chem (2001) 1.10
Peptide-based delivery of nucleic acids: design, mechanism of uptake and applications to splice-correcting oligonucleotides. Biochem Soc Trans (2007) 1.09
Antibody-targeted liposomes containing oligodeoxyribonucleotides complementary to viral RNA selectively inhibit viral replication. Proc Natl Acad Sci U S A (1990) 1.09
Impairment of reovirus mRNA methylation in extracts of interferon-treated Ehrilich ascites tumor cells: further characteristics of the phenomenon. J Virol (1977) 1.08
A unique ISRE, in the TATA-less human Isg20 promoter, confers IRF-1-mediated responsiveness to both interferon type I and type II. Nucleic Acids Res (2000) 1.07
Effect of aurintricarboxylic acid and of NaF on the binding of globin messenger RNA to reticulocyte 40S ribosomal subunits. Biochem Biophys Res Commun (1970) 1.07
Inhibition of reovirus messenger RNA methylation in extracts of interferon-treated Ehrlich ascites tumor cells. Biochem Biophys Res Commun (1975) 1.06
Injection of mice with antibody to mouse interferon alpha/beta decreases the level of 2'-5' oligoadenylate synthetase in peritoneal macrophages. J Virol (1985) 1.06
Interferon-induced disease in mice and rats. Ann N Y Acad Sci (1980) 1.06
Small tandemly repeated DNA sequences of higher plants likely originate from a tRNA gene ancestor. Nucleic Acids Res (1986) 1.04
Inhibition by interferon of thymidine uptake in chemostat cultures of L1210 cells. Intervirology (1978) 1.04
Inheritance of partial resistance against Colletotrichum lindemuthianum in Phaseolus vulgaris and co-localization of quantitative trait loci with genes involved in specific resistance. Mol Plant Microbe Interact (2000) 1.04
Reversible inhibition of gene expression by a psoralen functionalized triple helix forming oligonucleotide in intact cells. J Biol Chem (1994) 1.04